Folks who want solid protection during the cold and flu season should get the influenza vaccine now, the U.S. Food and Drug ...
The vaccine maker said the regulator placed the hold because of a report of a “serious adverse event” of motor neuropathy in ...
The so-called clinical hold is due to a single report of nerve damage in a patient who received the combination shot in a ...
However, Novavax's shares recently dropped by about 20% in one day after it announced a clinical setback. The biotech's stock ...
The U.S. Food and Drug Administration has put a trial of Novavax’s COVID-influenza and its standalone flu vaccines on hold after a participant who took the combination shot reported nerve damage, the ...
Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put the biooharma's flu ...
The hold, which was made in response to a serious adverse event report, could impact the company’s plans to start a Phase 3 trial of a combination shot for COVID-19 and influenza.
The Food and Drug Administration put clinical holds on Novavax's COVID-19 and flu combination vaccine and its standalone flu ...
Novavax shares tumbled after the Food and Drug Administration put a clinical hold on its testing applications for a combined ...
The Food and Drug Administration (FDA) is placing a hold on Novavax's (NVAX) experimental flu-COVID vaccines after a patient ...
The clinical hold affects Novavax’s COVID-flu combo and standalone flu vaccines, which were on the cusp of Phase III testing.
Cold and flu season — otherwise known as mid-October — is upon us. But this year, several advancements in vaccines could help ...